Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
1693 Results Found
CMS creates Office of Rural Health Transformation
The Centers for Medicare & Medicaid Services Dec. 19 announced the creation of the Office of Rural Health Transformation.
Sponsors
Education & Events
Check out our list of sponsors providing outstanding support to the AHA Rural Health Care Leadership Conference.
CMS announces voluntary model for providers who have not joined ACOs
The Centers for Medicare & Medicaid Services announced Dec. 18 that it will launch a voluntary payment model designed to broadly reach more health care providers who have not joined accountable care organizations, including those with specialized patient populations and others such as small, independent or rural-based practices.
Price Transparency Provisions in the CY 2026 OPPS/ASC Final Rules Webinar
This webinar reviews the latest changes to the Hospital Price Transparency requirements, which were finalized in the
Home Health Prospective Payment System Final Rule for CY 2026
The Centers for Medicare & Medicaid Services (CMS) Nov. 28 issued its final rule for the calendar year (CY) 2026 home health (HH) prospective payment system (PPS).
CMS announces pilot on MA service level data collection for initial determinations, appeals
The Centers for Medicare & Medicaid Services released a memo Dec. 16 announcing the agency’s intent to conduct a voluntary pilot in 2026, called the Service Level Data Collection for Initial Determinations and Appeals.
AHA 340B Advocacy Alliance Bulletin - December 16, 2025
AHA 340B Advocacy Alliance Bulletin - December 16, 2025.
Blog: Putting 340B Program Growth in Context
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.
Putting 340B Program Growth in Context
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.